ong-term effects of ADHD medication

Haukeland University Hospital0 个研究点目标入组 100,000 人开始时间: 2020年8月28日最近更新: 2023年9月18日

适应症

试验速览

2021 Protocol article in https://pubmed.ncbi.nlm.nih.gov/33468528/ protocol (added 22/01/2021) 2023 Results article in https://pubmed.ncbi.nlm.nih.gov/37385582/ (added 06/09/2023)

•The patient sample is all persons in Norway between 5 and 18 years of age that were in contact with child and adolescent psychiatric outpatient clinics in 2009-2011 (i.e. birth cohorts 1991-2006). We will also include a control sample that is a random sample from the general population of equal size to the patient sample. The control sample is defined as individuals in Norway between 5-18 years not in contact with child and adolescent psychiatric outpatient clinics (regardless of reason) during the calendar years 2009-2011.
•We have four different sample definitions:
•1. All patients diagnosed with ADHD in 2009-2011, regardless of referral reason
•2. All patients referred to child and adolescent outpatient clinics from GP’s with suspicion of ADHD in 2009-2011, regardless of whether the patient was diagnosed with ADHD
•3. All patients in contact with child and adolescent outpatient clinics for any reason in 2009-2011, regardless of whether the patient was diagnosed with ADHD
•4. All individuals in child and adolescent outpatient clinics catchment area in 2009-2011

发起方

Haukeland University Hospital